We hypothesized that non-proliferating (quiescent) human vascular endotheli
al cells would not express somatostatin receptor subtype 2 (sst 2) and that
this receptor would be expressed when the endothelial cells begin to grow.
To test this hypothesis, placental veins were harvested from 6 human place
ntas and 2 mm vein disks were cultured in 0.3% fibrin gels. Morphometric an
alysis confirmed that 50-75% of cultured vein disks developed radial capill
ary growth within 15 days. Sst 2 gene expression was determined by reverse
transcription-polymerase chain reaction (RT-PCR) analysis of the RNA from v
eins before culture and from tissue-matched vein disks that exhibited an an
giogenic response. The sst 2 gene was expressed in the proliferating angiog
enic sprouts of human vascular endothelium. The presence of sst 2 receptors
on proliferating angiogenic vessels was confirmed by immunohistochemical s
taining and in vivo scintigraphy. These results suggest that sst 2 may be a
unique target for antiangiogenic therapy with sst 2 preferring somatostati
n analogues conjugated to radioisotopes or cytotoxic agents. (C) 2001 Cance
r Research Campaign.